Nvidia Backs Recursion with $50M for AI-Powered Drug Discovery

Uncover the strategic move by Nvidia as they invest a substantial $50 million in Recursion, a pioneering force in AI-driven drug discovery. Delve into the potential innovations set to revolutionize the intersection of artificial intelligence and pharmaceuticals.

Get on the AI Box Waitlist: https://AIBox.ai/
Join our ChatGPT Community: https://www.facebook.com/groups/739308654562189/
Follow me on Twitter: https://twitter.com/jaeden_ai

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.